NMD4C Hiring a Postdoc to Develop Spinal Muscular Atrophy Decision Aid

NMD4C Hiring a Postdoc to Develop Spinal Muscular Atrophy Decision Aid

We are looking to fill a postdoctoral position to develop a tool to support decisions of families and clinicians in selecting a treatment plan for individuals affected by SMA.

This fellowship is based at the University of British Columbia (UBC) in collaboration with Muscular Dystrophy Canada (MDC) and the NMD4C in a well established and dynamic environment fosters professional development and interdisciplinary research collaborations.

With the support of the research team, the postdoctoral fellow will:

  • Acquire training on the Ottawa Decision Aid Framework
  • Conduct a decision need assessment among SMA leading clinicians and families
  • Develop a tool aid
  • Write a grant proposal for implementation and assessment of the SMA tool to CIHR

For further information please read the full job posting.

NMD4C Hiring a Postdoc to Develop Spinal Muscular Atrophy Decision Aid

Read next...

CPNG 2026

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.